लोड हो रहा है...
Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
BACKGROUND: Several dual bronchodilator combinations of long‐acting beta(2)‐agonist (LABA) and long‐acting muscarinic antagonist (LAMA) have been approved for treatment of stable chronic obstructive pulmonary disease (COPD). The current GOLD (Global Initiative for Chronic Obstructive Lung Disease) r...
में बचाया:
| में प्रकाशित: | Cochrane Database Syst Rev |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley & Sons, Ltd
2018
|
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517126/ https://ncbi.nlm.nih.gov/pubmed/30536566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011594.pub2 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|